Author: Philippe Pibarot

11.

The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes

Lansac E, Veen K, Joseph A, Jaber P, Sossi F, Das-Gupta Z, et al.

Eur J Cardiothorac Surg . 2025 Feb; 67(2). PMID: 39957685

Background: Globally significant variation in treatment and course of heart valve disease (HVD) exists, and outcome measurement is procedure focused instead of patient focused. This article describes the development of...

12.

The first International Consortium for Health Outcomes Measurement (ICHOM) standard dataset for reporting outcomes in heart valve disease: moving from device- to patient- centered outcomes

Lansac E, Veen K, Joseph A, Jaber P, Sossi F, Das-Gupta Z, et al.

Eur Heart J Qual Care Clin Outcomes . 2025 Feb; PMID: 39957667

Background: Globally significant variation in treatment and course of heart valve disease (HVD) exists, and outcome measurement is procedure focused instead of patient focused. This article describes the development of...

13.

The First International Consortium for Health Outcomes Measurement (ICHOM) Standard Dataset for Reporting Outcomes in Heart Valve Disease: Moving From Device- to Patient-Centered Outcomes

Lansac E, Veen K, Joseph A, Jaber P, Sossi F, Das-Gupta Z, et al.

Circ Cardiovasc Qual Outcomes . 2025 Feb; :e000128. PMID: 39957624

Background: Globally significant variation in treatment and course of heart valve disease (HVD) exists, and outcome measurement is procedure focused instead of patient focused. This article describes the development of...

14.

Evolution of Coagulation and Platelet Activation Markers After Transcatheter Edge-to-Edge Mitral Valve Repair

Hadjadj S, Beaudoin J, Beaupre F, Gravel C, Marsit O, Pouliot S, et al.

J Clin Med . 2025 Feb; 14(3). PMID: 39941501

The recommendations for antithrombotic therapy after transcatheter edge-to-edge mitral valve repair (TEER) are empirical, and the benefit of antiplatelet (APT) or anticoagulation therapy (ACT) remains undetermined. The study sought to...

15.

Prosthesis-Patient Mismatch: Current State of Evidence

Giuliani C, Zanuttini A, Hecht S, Ternacle J, Pibarot P

Curr Cardiol Rep . 2025 Feb; 27(1):49. PMID: 39928182

Purpose Of Review: Prosthesis-patient mismatch (PPM) remains a significant concern in valve intervention. This review highlights the current evidence surrounding PPM, compares its impact after surgical aortic valve replacement (SAVR)...

16.

The Reversibility of Cardiac Damage After Transcatheter Aortic Valve Implantation and Short-Term Outcomes in a Real-World Setting

Myagmardorj R, Fortuni F, Genereux P, Nabeta T, Stassen J, Galloo X, et al.

Eur Heart J Cardiovasc Imaging . 2025 Feb; PMID: 39903642

Aims: This study aims to assess the changes in cardiac damage stage in a real-world cohort of patients undergoing transcatheter aortic valve implantation (TAVI) and to investigate the prognostic value...

17.

Factors associated with heart failure events in patients with new-onset persistent left bundle branch block at discharge after transcatheter aortic valve replacement

Echivard M, Vaxelaire N, Pibarot P, Lamiral Z, Freysz L, Popovic B, et al.

Heart Rhythm . 2025 Feb; PMID: 39894134

Background: New-onset persistent left bundle branch block (NOP-LBBB) at discharge after transcatheter aortic valve replacement (TAVR) is frequent, but its association with death and hospitalization for heart failure (HHF) remains...

18.

Effect of Early Menopause and Hormone Replacement Therapy on Aortic Stenosis Progression

Abdoun K, Tastet L, Bedard E, Arsenault M, Pibarot P, Clavel M

Can J Cardiol . 2025 Jan; PMID: 39884462

Background: Early menopause has been associated with several cardiovascular diseases. Its effect on the progression of aortic stenosis (AS) remains unknown. We conducted an analysis to examine the effect of...

19.

The Role of Multimodality Imaging in Multiple Valvular Heart Diseases. A Clinical Consensus Statement of the European Association of Cardiovascular Imaging (EACVI) of the ESC

Donal E, Unger P, Coisne A, Pibarot P, Magne J, Sitges M, et al.

Eur Heart J Cardiovasc Imaging . 2025 Jan; PMID: 39874243

With this document, the European Association of Cardiovascular Imaging (EACVI) provides an Expert Consensus on the role of multi-modality imaging (MMI) in the management of patients with multiple valvular heart...

20.

Epicardial adipose tissue, cardiac damage, and mortality in patients undergoing TAVR for aortic stenosis

Pina P, Lorenzatti D, Filtz A, Scotti A, Gil E, Torres J, et al.

Int J Cardiovasc Imaging . 2025 Jan; 41(2):279-290. PMID: 39825067

Computed tomography (CT)-derived Epicardial Adipose Tissue (EAT) is linked to cardiovascular disease outcomes. However, its role in patients undergoing Transcatheter Aortic Valve Replacement (TAVR) and the interplay with aortic stenosis...